Multidimensional flow cytometry immunophenotyping of hematologic malignancy

Annals of the New York Academy of Sciences

Volumn 963, Issue , 2002, Pages 313-321

  Pagnucco, Guido ^a,b,c   Vanelli, Laura ^b   Gervasi, Francesco ^a  

^a ARNAS General Hospital Civico and Benfratelli   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c ARNAS Civico   (Italy)

Author keywords

Flow cytometry; Hematologic malignancy; Immunophenotyping

Indexed keywords

ANALYTIC METHOD; BLOOD DYSCRASIA; CELL DIFFERENTIATION; CELL MATURATION; CLINICAL EXAMINATION; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FLOW CYTOMETRY; GENETIC ANALYSIS; HEMATOLOGIC DISEASE; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LYMPHOPROLIFERATIVE DISEASE; PHENOTYPE; TUMOR CELL;

EID: 0036291323     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2002.tb04123.x     Document Type: Conference Paper

References (33)

1. Recent advances in flow cytometry: Application to the diagnosis of hematologic malignancy
2. U.S.-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: Medical indications
3. Impact of immunophenotyping on management of acute leukemias
4. Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies
5. U.S.-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: Data analysis and interpretation
6. Report on the first Latin American consensus conference for flow cytometric immunophenotyping of leukemia
7. Optimal number of reagents required to evaluate hematolymphoid neoplasias: Results of an international consensus meeting
8. Monoclonal antibody panels for acute leukemia and myelodysplastic sindrome diagnosis. Results of a co-operative quality control group
9. Immunobiology of leukemia
10. Correlation of karyotype and immunophenotype in childhood acute lymphoblastic leukemia
11. Expression of unusual immunophenotype combinations in acute myelogenous leukemia
12. Correlation of CD2 expression with PML gene breakpoints in patients with acute promyelocytic leukemia
13. Acute myeloid leukemia M4 with bone marrow eosinophilia (M4Eo) and inv(16) (p13q22) exhibits a specific immunophenotype with CD2 expression
14. Proposals for the immunological classification of acute leukemias
15. U.S.-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: Standardization of laboratory procedures
16. U.S.-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: Selection of antibody combinations
17. Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma
18. Flow cytometric analysis of normal B cell differentiation: A frame of reference for the detection of minimal residual disease in precursor-B-ALL
19. Detection of abnormalities in B-cell differentiation pattern is a useful tool to predict relapse in precursor-B-ALL
20. BIOMED-1 concerted action report: Flow cytometric characterization of CD7+ cell subsets in normal bone marrow as a basis for the diagnosis and follow-up of T cell acute lymphoblastic leukemia (T-ALL)
21. Minimal residual disease in acute myeloid malignancies
22. CD45 gating for routine flow cytometric analysis of human bone marrow specimens
23. Immunophenotyping of acute leukemia by flow cytometric analysis: Use of CD45 and right-angle light scatter to gate on leukemic blasts in three-color analysis
24. Flow cytometric analysis of aberrant antigen expression of blasts using CD45 blast gating for minimal residual disease in acute leukemia and high-risk myelodysplastic syndrome
25. The flow cytometric pattern of CD34, CD15, and CD13 expression in acute myeloblastic leukemia is highly characteristic of the presence of PML-RARalpha gene rearrangements
26. Acute myeloid leukemia M2 and t(8;21)(q22;q22) with an unusual phenotype: Myeloperoxidase (+), CD13 (-), CD14 (-), and CD33 (-)
27. Complete remission in acute myeloid leukaemia with t(8;21) following treatment with G-CSF: Flow cytometric analysis of in vivo and in vitro effects on cell maturation
28. Diagnostic utlity of flow cytometric immunophenotyping in myelodysplastic syndrome
29. + precursors in normal human adult bone marrow: Implications for minimal residual disease detection
30. Quantitative multiparametric immunophenotyping in acute lymphoblastic leukemia: Correlation with specific genotype. I. ETV6/AML1 ALLs identification
31. Adult precursor B-ALL with BCR/ABL gene rearrangements displays a unique immunophenotype based on the pattern of CD10, CD34, CD13 and CD38 expression
32. CD79b expression in B cell chronic lymphocytic leukemia: Its implication for minimal residual disease detection
33. Circulating plasma cell in multiple myeloma: Characterization and correlation with disease stage